Updated Australian HF guidelines in 2011 recommended the use of ACE inhibitor/angiotensin II receptor blockers, β-blockers and aldosterone antagonist,17 however, only 27% were on this recommended combination therapy. This evidence concerns the gene ACE and hydrops fetalis.